Avian influenza virus, Streptococcus suis serotype 2, severe acute respiratory syndrome-coronavirus and beyond: molecular epidemiology, ecology and the situation in China.
The outbreak and spread of severe acute respiratory syndrome-associated coronavirus and the subsequent identification of its animal origin study have heightened the world's awareness of animal-borne or zoonotic pathogens. In addition to SARS, the highly pathogenic avian influenza virus (AIV), H5N1, and the lower pathogenicity H9N2 AIV have expanded their host ranges to infect human beings and other mammalian species as well as birds. Even the 'well-known' reservoir animals for influenza virus, migratory birds, became victims of the highly pathogenic H5N1 virus. Not only the viruses, but bacteria can also expand their host range: a new disease, streptococcal toxic shock syndrome, caused by human Streptococcus suis serotype 2 infection, has been observed in China with 52 human fatalities in two separate outbreaks (1998 and 2005, respectively). Additionally, enterohaemorrhagic Escherichia coli O157:H7 infection has increased worldwide with severe disease. Several outbreaks and sporadic isolations of this pathogen in China have made it an important target for disease control. A new highly pathogenic variant of porcine reproductive and respiratory syndrome virus (PRRSV) has been isolated in both China and Vietnam recently; although PRRSV is not a zoonotic human pathogen, its severe outbreaks have implications for food safety. All of these pathogens occur in Southeast Asia, including China, with severe consequences; therefore, we discuss the issues in this article by addressing the situation of the zoonotic threat in China.
Ma
Ying
Y
CAS Key Laboratory of Pathogenic Microbiology and Immunology (CASPMI), Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, The People's Republic of China.
Feng
Youjun
Y
Liu
Di
D
Gao
George F
GF
D000818:Animals; D002681:China / Q000453:epidemiology; D017753:Ecosystem; D004927:Escherichia coli Infections / Q000453:epidemiology* / Q000382:microbiology; D019453:Escherichia coli O157 / Q000302:isolation & purification; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000302:isolation & purification; D007251:Influenza, Human / Q000453:epidemiology* / Q000821:virology; D017720:Molecular Epidemiology; D045473:Severe acute respiratory syndrome-related coronavirus / Q000302:isolation & purification; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology* / Q000821:virology; D013290:Streptococcal Infections / Q000453:epidemiology* / Q000382:microbiology; D013291:Streptococcus / Q000302:isolation & purification; D015047:Zoonoses / Q000453:epidemiology* / Q000821:virology
J Clin Virol. 2004 Jan;29(1):13-22
14675864
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19368-73
17158217
J Virol. 2005 Sep;79(18):11892-900
16140765
N Engl J Med. 2003 Dec 18;349(25):2431-41
14681510
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2430-5
15695582
Vet Q. 1991 Jul;13(3):121-30
1835211
J Virol. 2008 Jan;82(2):596-601
17942553
Virology. 2005 Feb 5;332(1):167-76
15661149
Emerg Infect Dis. 2006 Aug;12(8):1203-8
16965698
J Virol. 2007 Jul;81(14):7371-9
17494075
N Engl J Med. 2003 May 15;348(20):1953-66
12690092
J Gen Virol. 2008 Mar;89(Pt 3):697-702
18272760
Lancet. 1999 Sep 11;354(9182):916-7
10489954
Zoonoses Public Health. 2009 Nov;56(9-10):506-14
19538458
Lancet. 2008 Apr 26;371(9622):1427-34
18400288
Comp Immunol Microbiol Infect Dis. 2007 Sep;30(5-6):309-27
17640731
J Virol. 2007 Sep;81(18):9878-90
17522233
PLoS Med. 2006 May;3(5):e151
16584289
Science. 2003 Oct 10;302(5643):276-8
12958366
Lancet Infect Dis. 2004 Nov;4(11):663-71
15522678
Science. 2004 Mar 12;303(5664):1666-9
14752165
Lancet. 1998 Feb 14;351(9101):472-7
9482438
Science. 1997 Sep 5;277(5331):1453-62
9278503
Arch Virol. 1997;142(3):629-33
9349308
PLoS Med. 2006 Sep;3(9):e343
16968120
Emerg Infect Dis. 2002 Feb;8(2):154-9
11897066
Lancet. 2003 Nov 29;362(9398):1807-8
14654320
Lancet. 1978 Nov 25;2(8100):1116-8
82681
PLoS One. 2007 Jun 13;2(6):e526
17565379
J Infect Dis. 2009 Jan 1;199(1):97-107
19016627
PLoS One. 2007 Mar 21;2(3):e315
17375201
Science. 2000 Jul 28;289(5479):518-9
10939954
Clin Exp Immunol. 2008 Sep;153(3):385-91
18803762
J Virol. 2006 Jun;80(12):5976-83
16731936
J Gen Virol. 2008 Sep;89(Pt 9):2075-2079
18753215
Virus Res. 2008 Apr;133(1):101-12
17451827
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1999 Jun 30;13(2):105-8
12569771
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9654-8
10920197
Vet Res. 2000 Jan-Feb;31(1):77-83
10726639
J Virol. 2004 Oct;78(20):11334-9
15452254
Virology. 2005 Sep 15;340(1):70-83
16026813
N Engl J Med. 2003 May 15;348(20):1967-76
12690091
Lancet. 2004 Jan 10;363(9403):99-104
14726162
J Virol. 2008 Apr;82(7):3405-14
18216109
Adv Nurse Pract. 2008 Oct;16(10):69-72
19178022
Clin Infect Dis. 2004 May 15;38(10):1420-7
15156481
Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1081-2
15306393
J Virol. 2005 Mar;79(6):3692-702
15731263
Curr Top Microbiol Immunol. 2007;315:325-44
17848070
N Engl J Med. 2004 Mar 25;350(13):1366-7
15044654
J Virol. 2003 Jun;77(12):6988-94
12768017
J Struct Funct Genomics. 2007 Sep;8(2-3):85-97
17680348
PLoS Med. 2006 Jul;3(7):e237
16796401
J Gen Virol. 2007 Feb;88(Pt 2):536-546
17251572
N Engl J Med. 1987 Jul 16;317(3):146-9
3299086
N Engl J Med. 2006 Mar 30;354(13):1421-2
16571888
Nat Med. 2005 Sep;11(9):944-51
16116432
N Engl J Med. 1983 Mar 24;308(12):681-5
6338386
Arch Virol. 2004 Jul;149(7):1341-51
15221535
Biochem Biophys Res Commun. 2005 Apr 29;330(1):39-45
15781229
Vet Microbiol. 2007 Jul 20;123(1-3):43-52
17383833
Virology. 1988 Mar;163(1):247-50
3348002
Virus Res. 2008 Apr;133(1):4-12
17825937
Emerg Infect Dis. 2008 Nov;14(11):1774-6
18976568
Antivir Ther. 2005;10(5):681-90
16152762
Med J Aust. 2008 May 5;188(9):538-9
18459929
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9363-7
10430948
J Biol Chem. 2004 Nov 19;279(47):49414-9
15345712
J Gen Virol. 2003 Sep;84(Pt 9):2305-2315
12917450
Vet Microbiol. 1997 Apr;55(1-4):309-16
9220627
J Virol. 2003 Aug;77(15):8207-15
12857889
Ann N Y Acad Sci. 2007 Apr;1102:26-38
17470909
Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):1063-81
17327210
Lancet. 1982 Oct 9;2(8302):812-3
6126676
Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):9062-7
15956182
J Clin Virol. 2008 Oct;43(2):236-40
18707918
Virus Res. 2008 Apr;133(1):74-87
17451830
Biochem Biophys Res Commun. 2004 Jun 18;319(1):283-8
15158473
PLoS One. 2008 May 07;3(5):e2080
18461172
J Gen Virol. 2006 Jul;87(Pt 7):1835-1841
16760385
Nature. 2005 Jul 14;436(7048):191-2
16007072
Avian Dis. 1970 Feb;14(1):66-74
4314007
Science. 2005 Aug 19;309(5738):1206
16000410
PLoS Biol. 2005 Oct;3(10):e324
16128623
Lancet. 2008 Apr 26;371(9622):1464-75
18440429
Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25
10511517
J Virol. 2006 May;80(9):4211-9
16611880
J Occup Med. 1992 Nov;34(11):1102-5
1432301
Science. 2003 May 30;300(5624):1394-9
12730500
J Clin Microbiol. 1999 Oct;37(10):3426-7
10488228
Arch Virol. 2004 Nov;149(11):2095-104
15503199
J Med Microbiol. 1975 Feb;8(1):107-11
1092859
Virology. 2006 Jul 5;350(2):258-68
16713612
Nat Med. 2004 Dec;10(12 Suppl):S88-97
15577937
Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52
15530413
PLoS One. 2007 Sep 26;2(9):e950
17895991
Annu Rev Immunol. 2007;25:443-72
17243893
Science. 2003 May 30;300(5624):1399-404
12730501
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16936-41
17075062
Science. 2005 Oct 28;310(5748):676-9
16195424
Emerg Infect Dis. 2006 Jun;12(6):914-20
16707046
J Gen Virol. 2000 Aug;81(Pt 8):1927-1932
10900029
Virology. 2000 Feb 15;267(2):279-88
10662623